Results 121 to 130 of about 3,820 (178)

HCMV infection disrupts barrier functions and promotes epithelial-mesenchymal transition in a cholangiocyte organoid model. [PDF]

open access: yesNat Commun
Ye Z   +12 more
europepmc   +1 more source

Machine Perfusion Across Marginal Liver Grafts: Benefits and Challenges. [PDF]

open access: yesJ Pers Med
Sierra L   +8 more
europepmc   +1 more source

Ischemic cholangiopathy: An update

Clinics and Research in Hepatology and Gastroenterology, 2020
Aurélie Plessier   +2 more
exaly   +3 more sources

Macrophages in cholangiopathies

Current Opinion in Gastroenterology, 2021
Purpose of review Cholangiopathies are a heterogeneous class of liver diseases where cholangiocytes are the main targets of liver injury. Although available and emerging therapies mainly target bile acids (ursodeoxycholic acid/UDCA, 24-Norursodeoxycholic acid/norUDCA) and related signaling pathways (obeticholic acid, fibrates ...
Alix, Bruneau   +2 more
openaire   +2 more sources

Cellular senescence in the cholangiopathies

Current Opinion in Gastroenterology, 2021
Purpose of review Cellular senescence (i.e. permanent withdrawal from the cell cycle) is increasingly recognized as a pathologic feature in a variety of inflammatory liver diseases, including primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC) and additional cholangiopathies.
Pamela S, Bogert   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy